The Point-Of-Care diagnosis has become a promising strategy

Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, growing government support, and rising preference for home medical service across the globe are driving the growth of the market.

Click to watch our CER Kelvin’s sharing on HKMHDIA’s interview video: HERE

– A portable fluorescent immunoassay analyzer

Empowering decentralized hospitals clinical diagnostics and fast patient triage, e.g. borders, rural areas, airplanes, cruise ships and farms

– A single use user-friendly BioChip

Utilizing proprietary automated microfluidic and multiplex protein microarray technologies

– Test in 15 minutes

Leading to much quicker health treatment to patients and virus containment

– Multiple results in 1 test

Reducing diagnostics costs and sample use

– Central data bank for disease monitoring

Creating digital health system with embedded big data analytics platform

Other updates